FERMENTA BIOTECH
|
FERMENTA BIOTECH Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -17.85 | 5.35 | 15.77 | 20.63 | 128.05 |
| CEPS(Rs) | -8.77 | 14.08 | 21.78 | 25.83 | 47.16 |
| DPS(Rs) | 1.25 | 1.25 | 2.50 | 5.00 | 1.25 |
| Book NAV/Share(Rs) | 104.44 | 123.91 | 120.84 | 105.16 | 261.22 |
| Tax Rate(%) | -3.24 | 44.10 | 17.63 | -37.08 | 8.39 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 5.29 | 15.62 | 21.89 | 21.95 | 33.44 |
| EBIT Margin(%) | -8.72 | 11.27 | 18.72 | 21.68 | 37.05 |
| Pre Tax Margin(%) | -14.82 | 6.76 | 13.68 | 14.82 | 31.81 |
| PAT Margin (%) | -15.30 | 3.78 | 11.27 | 20.32 | 29.14 |
| Cash Profit Margin (%) | -7.23 | 10.19 | 16.66 | 25.44 | 32.07 |
| Performance Ratios | |||||
| ROA(%) | -7.69 | 2.04 | 6.56 | 10.75 | 25.73 |
| ROE(%) | -16.26 | 4.27 | 13.05 | 21.92 | 64.77 |
| ROCE(%) | -5.35 | 7.50 | 12.62 | 12.98 | 40.16 |
| Asset Turnover(x) | 0.50 | 0.54 | 0.58 | 0.53 | 0.88 |
| Sales/Fixed Asset(x) | 1.08 | 1.25 | 1.52 | 1.98 | 3.33 |
| Working Capital/Sales(x) | 7.90 | 3.73 | 3.76 | 3.28 | 2.90 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.93 | 0.80 | 0.66 | 0.50 | 0.30 |
| Receivable days | 67.14 | 71.03 | 66.65 | 84.30 | 60.55 |
| Inventory Days | 151.04 | 147.34 | 140.69 | 134.72 | 62.62 |
| Payable days | 131.18 | 150.99 | 160.90 | 228.76 | 163.81 |
| Valuation Parameters | |||||
| PER(x) | - | 38.41 | 15.87 | 10.31 | 2.14 |
| PCE(x) | -12.20 | 14.61 | 11.49 | 8.24 | 5.82 |
| Price/Book(x) | 1.02 | 1.66 | 2.07 | 2.02 | 3.15 |
| Yield(%) | 1.17 | 0.61 | 1.00 | 2.35 | 0.15 |
| EV/Net Sales(x) | 1.34 | 2.00 | 2.40 | 2.73 | 2.16 |
| EV/Core EBITDA(x) | 17.82 | 11.29 | 9.97 | 10.20 | 5.39 |
| EV/EBIT(x) | -15.32 | 17.72 | 12.84 | 12.61 | 5.82 |
| EV/CE(x) | 0.73 | 1.06 | 1.26 | 1.39 | 1.64 |
| M Cap / Sales | 0.88 | 1.49 | 1.91 | 2.09 | 1.87 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -12.19 | 5.63 | 28.79 | -27.61 | 33.70 |
| Core EBITDA Growth(%) | -62.79 | -22.50 | 15.84 | -51.48 | 58.70 |
| EBIT Growth(%) | -167.90 | -36.40 | 11.22 | -57.64 | 67.33 |
| PAT Growth(%) | -455.59 | -64.59 | -28.54 | -49.52 | 115.01 |
| EPS Growth(%) | -433.26 | -66.06 | -23.55 | -83.88 | -12.91 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.72 | 0.66 | 0.66 | 0.73 | 0.87 |
| Current Ratio(x) | 1.19 | 1.47 | 1.44 | 1.46 | 1.90 |
| Quick Ratio(x) | 0.63 | 0.77 | 0.73 | 0.80 | 1.33 |
| Interest Cover(x) | -1.43 | 2.50 | 3.72 | 3.16 | 7.06 |
| Total Debt/Mcap(x) | 0.69 | 0.39 | 0.31 | 0.35 | 0.28 |
Compare Financial Ratios of peers of FERMENTA BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FERMENTA BIOTECH | ₹497.7 Cr | -2.2% | -23.9% | 14.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹369,774.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
| CIPLA | ₹111,518.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,258.0 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹98,636.2 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹94,082.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics | |
FERMENTA BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FERMENTA BIOTECH | -2.2% |
-23.9% |
14.6% |
| SENSEX | -1.1% |
-0.1% |
22.7% |
You may also like the below Video Courses
